AbbVie Stock

AbbVie Directors Dealings

Ticker

ABBV

ISIN

US00287Y1091

Total Trades

892

Revenue Net Income P/E P/S EBIT Dividend Directors Dealings Stocks Market capitalization Debt Liabilities Equity AAQS Employees ROE ROA ROCE News

AbbVie News

Buy
Sell

AbbVie News

AbbVie News
YEARBuySell Net Total Trades
— 01.22 M USD 1−1.22 M USD1
223,620.79 USD 75119.73 M USD 44−119.50 M USD119
23.98 M USD 27173.57 M USD 38−149.59 M USD65
84,727.05 USD 1495.68 M USD 40−95.59 M USD54
7.58 M USD 75233.73 M USD 76−226.14 M USD151
15.32 M USD 60131.57 M USD 49−116.25 M USD109
19.22 M USD 1662.56 M USD 21−43.34 M USD37
4.29 M USD 1111.03 M USD 8−6.75 M USD19
5.44 M USD 1848.86 M USD 21−43.42 M USD39
16.86 M USD 1341.17 M USD 80−24.31 M USD93
269,588.68 USD 210.87 M USD 13−10.60 M USD15
6.49 M USD 1925.51 M USD 90−19.02 M USD109
862,407.18 USD 197.88 M USD 44−7.02 M USD63
168,259.79 USD 16401,034.11 USD 2−232,774.32 USD18
Sell

Purdue David Ryan

1,221,518.80 USD

5,230 × 233.56
Buy

Quaggin Susan E

15,537.32 USD

68 × 228.49
Buy

Alpern Robert J

7,768.66 USD

34 × 228.49
Buy

RAPP EDWARD J

33,588.03 USD

147 × 228.49
Buy

Quaggin Susan E

15,513.18 USD

67 × 231.54
Buy

Alpern Robert J

7,640.82 USD

33 × 231.54
Buy

RAPP EDWARD J

33,573.30 USD

145 × 231.54
Sell

SALEKI-GERHARDT AZITA

2,324,418.20 USD

42,370 × 54.86
Sell

SALEKI-GERHARDT AZITA

8,407,055.00 USD

42,370 × 198.42
Sell

Donoghoe Nicholas

1,998,014.00 USD

10,061 × 198.59
Sell

Donoghoe Nicholas

641,205.20 USD

3,234 × 198.27
Buy

Quaggin Susan E

15,035.22 USD

81 × 185.62
Buy

Alpern Robert J

7,424.80 USD

40 × 185.62
Buy

RAPP EDWARD J

32,854.74 USD

177 × 185.62
Buy

Quaggin Susan E

—

1,203 × —
Buy

MEYER MELODY B

—

1,203 × —
Buy

Davis Jennifer L.

—

1,203 × —
Buy

BURNSIDE WILLIAM H.L.

—

1,203 × —
Buy

Hart Brett J

—

1,203 × —
Buy

Alpern Robert J

—

1,203 × —
Buy

Roberts Rebecca B

—

1,203 × —
Buy

FREYMAN THOMAS C

—

1,203 × —
Buy

WADDELL FREDERICK H

—

1,203 × —
Buy

FALK THOMAS J

—

1,203 × —
Buy

TILTON GLENN F

—

1,203 × —
Buy

RAPP EDWARD J

—

1,203 × —
Buy

AUSTIN ROXANNE S

—

1,203 × —
Buy

Quaggin Susan E

14,875.92 USD

71 × 209.52
Sell

Stewart Jeffrey Ryan

2,030,813.90 USD

25,700 × 79.02
Sell

Stewart Jeffrey Ryan

6,975,611.00 USD

33,132 × 210.54
Sell

Stewart Jeffrey Ryan

5,383,893.00 USD

25,700 × 209.49
Buy

Alpern Robert J

7,333.20 USD

35 × 209.52
Sell

GONZALEZ RICHARD A

—

2,450 × —
Buy

RAPP EDWARD J

32,475.60 USD

155 × 209.52
Sell

Reents Scott T

3,746,527.00 USD

17,644 × 212.34
Sell

RICHMOND TIMOTHY J.

126,792.01 USD

600 × 211.32
Sell

RICHMOND TIMOTHY J.

3,154,212.20 USD

14,973 × 210.66
Sell

RICHMOND TIMOTHY J.

1,191,034.60 USD

5,677 × 209.80
Sell

Siatis Perry C

1,362,802.00 USD

7,775 × 175.28
Sell

Siatis Perry C

1,094,470.20 USD

7,315 × 149.62
Sell

Siatis Perry C

421,767.70 USD

2,918 × 144.54
Sell

Siatis Perry C

3,781,680.00 USD

18,008 × 210.00
Sell

GONZALEZ RICHARD A

1,298,549.00 USD

6,168 × 210.53
Sell

Thakkar Roopal

959,083.56 USD

4,678 × 205.02
Sell

Buckbee Kevin K

758,369.00 USD

3,699 × 205.02
Sell

Donoghoe Nicholas

2,302,374.80 USD

11,230 × 205.02
Sell

Reents Scott T

2,249,684.50 USD

10,973 × 205.02
Sell

Michael Robert A.

5,573,674.00 USD

27,186 × 205.02
Sell

Stewart Jeffrey Ryan

4,146,734.50 USD

20,226 × 205.02
Sell

SALEKI-GERHARDT AZITA

3,496,821.20 USD

17,056 × 205.02
Sell

RICHMOND TIMOTHY J.

3,465,658.20 USD

16,904 × 205.02
Sell

Siatis Perry C

75,209.97 USD

363 × 207.19
Sell

Siatis Perry C

1,407,288.80 USD

6,811 × 206.62
Sell

Siatis Perry C

558,222.90 USD

2,718 × 205.38
Sell

Siatis Perry C

1,613,507.40 USD

7,870 × 205.02
Sell

GONZALEZ RICHARD A

18,964,470.00 USD

92,460 × 205.11
Sell

GONZALEZ RICHARD A

15,009,309.00 USD

73,209 × 205.02
Sell

Buckbee Kevin K

690,810.25 USD

6,522 × 105.92
Sell

Buckbee Kevin K

910,503.00 USD

9,738 × 93.50
Sell

Buckbee Kevin K

3,307,446.80 USD

16,260 × 203.41
Sell

Buckbee Kevin K

545,925.56 USD

2,684 × 203.40
Sell

RICHMOND TIMOTHY J.

2,539,935.50 USD

22,210 × 114.36
Sell

RICHMOND TIMOTHY J.

983,329.30 USD

4,829 × 203.63
Sell

RICHMOND TIMOTHY J.

2,652,773.20 USD

13,073 × 202.92
Sell

RICHMOND TIMOTHY J.

870,086.75 USD

4,308 × 201.97
Sell

RICHMOND TIMOTHY J.

310,754.62 USD

1,526 × 203.64
Sell

RICHMOND TIMOTHY J.

970,208.30 USD

4,781 × 202.93
Sell

RICHMOND TIMOTHY J.

282,884.00 USD

1,400 × 202.06
Sell

Siatis Perry C

791,291.25 USD

3,994 × 198.12
Sell

Siatis Perry C

352,161.60 USD

1,784 × 197.40
Buy

Donoghoe Nicholas

—

23,437 × —
Buy

Donoghoe Nicholas

—

5,174 × —
Buy

Donoghoe Nicholas

—

4,634 × —
Buy

Donoghoe Nicholas

—

4,520 × —
Buy

Donoghoe Nicholas

—

11,017 × —
Buy

Buckbee Kevin K

—

6,250 × —
Buy

Buckbee Kevin K

—

1,674 × —
Buy

Buckbee Kevin K

—

1,604 × —
Buy

Buckbee Kevin K

—

1,474 × —
Buy

Buckbee Kevin K

—

3,595 × —
Buy

Thakkar Roopal

—

25,000 × —
Buy

Thakkar Roopal

—

3,348 × —
Buy

Thakkar Roopal

—

2,138 × —
Buy

Thakkar Roopal

—

1,474 × —
Buy

Thakkar Roopal

—

3,595 × —
Buy

Stewart Jeffrey Ryan

—

33,854 × —
Buy

Stewart Jeffrey Ryan

—

9,432 × —
Buy

Stewart Jeffrey Ryan

—

9,268 × —
Buy

Stewart Jeffrey Ryan

—

7,840 × —
Buy

Stewart Jeffrey Ryan

—

19,111 × —
Buy

Siatis Perry C

—

21,875 × —
Buy

Siatis Perry C

—

5,630 × —
Buy

Siatis Perry C

—

5,792 × —
Buy

Siatis Perry C

—

1,844 × —
Buy

Siatis Perry C

—

4,496 × —
Buy

SALEKI-GERHARDT AZITA

—

25,000 × —
Buy

SALEKI-GERHARDT AZITA

—

7,074 × —
Buy

SALEKI-GERHARDT AZITA

—

6,060 × —
Buy

SALEKI-GERHARDT AZITA

—

7,378 × —
Buy

SALEKI-GERHARDT AZITA

—

17,986 × —
Buy

RICHMOND TIMOTHY J.

—

22,916 × —
Buy

RICHMOND TIMOTHY J.

—

6,998 × —
Buy

RICHMOND TIMOTHY J.

—

5,792 × —
Buy

RICHMOND TIMOTHY J.

—

7,378 × —
Buy

RICHMOND TIMOTHY J.

—

17,986 × —
Buy

Reents Scott T

—

27,343 × —
Buy

Reents Scott T

—

7,608 × —
Buy

Reents Scott T

—

8,912 × —
Buy

Reents Scott T

—

2,398 × —
Buy

Reents Scott T

—

5,845 × —
Buy

Michael Robert A.

—

83,333 × —
Buy

Michael Robert A.

—

14,454 × —
Buy

Michael Robert A.

—

12,030 × —
Buy

Michael Robert A.

—

10,146 × —
Buy

Michael Robert A.

—

24,732 × —
Buy

GONZALEZ RICHARD A

—

65,104 × —
Buy

GONZALEZ RICHARD A

—

27,386 × —
Buy

GONZALEZ RICHARD A

—

30,298 × —
Buy

GONZALEZ RICHARD A

—

33,208 × —
Buy

GONZALEZ RICHARD A

—

80,945 × —
Sell

Buckbee Kevin K

168,300.00 USD

1,800 × 93.50
Sell

Buckbee Kevin K

310,032.00 USD

1,800 × 172.24
Buy

RAPP EDWARD J

32,386.72 USD

164 × 197.48
Buy

Quaggin Susan E

14,811.00 USD

75 × 197.48
Sell

GONZALEZ RICHARD A

—

36,698 × —
Sell

GONZALEZ RICHARD A

—

15,729 × —
Sell

GONZALEZ RICHARD A

—

5,243 × —
Buy

Alpern Robert J

7,306.76 USD

37 × 197.48
Sell

SALEKI-GERHARDT AZITA

—

25,630 × —
Sell

GONZALEZ RICHARD A

12,403,580.00 USD

66,500 × 186.52
Sell

GONZALEZ RICHARD A

—

76,377 × —
Sell

GONZALEZ RICHARD A

—

119,418 × —
Sell

GONZALEZ RICHARD A

—

87,050 × —
Sell

GONZALEZ RICHARD A

49,497,876.00 USD

282,845 × 175.00
Buy

GONZALEZ RICHARD A

7,141,249.50 USD

76,377 × 93.50
Buy

GONZALEZ RICHARD A

9,436,410.00 USD

119,418 × 79.02
Buy

GONZALEZ RICHARD A

5,341,388.00 USD

87,050 × 61.36
Buy

Quaggin Susan E

14,922.24 USD

87 × 171.52
Buy

RAPP EDWARD J

38,592.00 USD

225 × 171.52
Buy

Alpern Robert J

7,375.36 USD

43 × 171.52
Sell

GONZALEZ RICHARD A

—

6,000 × —
Buy

Davis Jennifer L.

—

1,322 × —
Buy

Quaggin Susan E

—

1,322 × —
Buy

FREYMAN THOMAS C

—

1,322 × —
Buy

Alpern Robert J

—

1,322 × —
Buy

RAPP EDWARD J

—

1,322 × —
Buy

AUSTIN ROXANNE S

—

1,322 × —
Buy

Roberts Rebecca B

—

1,322 × —
Buy

Hart Brett J

—

1,322 × —
Buy

MEYER MELODY B

—

1,322 × —
Buy

TILTON GLENN F

—

1,322 × —
Buy

BURNSIDE WILLIAM H.L.

—

1,322 × —
Buy

WADDELL FREDERICK H

—

1,322 × —
Buy

Quaggin Susan E

14,932.20 USD

82 × 182.10
Buy

Alpern Robert J

7,466.10 USD

41 × 182.10
Buy

RAPP EDWARD J

38,605.20 USD

212 × 182.10
Sell

Donoghoe Nicholas

3,716,756.80 USD

21,082 × 176.30
Sell

Stewart Jeffrey Ryan

1,602,109.60 USD

26,110 × 61.36
Sell

Stewart Jeffrey Ryan

4,956,860.50 USD

27,740 × 178.69
Sell

Stewart Jeffrey Ryan

912,873.94 USD

5,099 × 179.03
Sell

Stewart Jeffrey Ryan

4,669,773.50 USD

26,110 × 178.85
Sell

Reents Scott T

2,082,369.80 USD

11,634 × 178.99
Sell

Michael Robert A.

6,736,826.00 USD

37,638 × 178.99
Sell

Buckbee Kevin K

955,627.60 USD

5,339 × 178.99
Sell

Siatis Perry C

1,411,336.20 USD

7,885 × 178.99
Sell

Stewart Jeffrey Ryan

4,675,398.00 USD

26,121 × 178.99
Sell

RICHMOND TIMOTHY J.

4,268,374.50 USD

23,847 × 178.99
Sell

SALEKI-GERHARDT AZITA

4,289,674.50 USD

23,966 × 178.99
Sell

Thakkar Roopal

879,556.90 USD

4,914 × 178.99
Sell

Hudson Thomas J

3,693,279.80 USD

20,634 × 178.99
Sell

Donoghoe Nicholas

3,001,841.50 USD

16,771 × 178.99
Sell

GONZALEZ RICHARD A

24,572,458.00 USD

138,616 × 177.27
Sell

GONZALEZ RICHARD A

19,733,470.00 USD

110,249 × 178.99
Sell

GONZALEZ RICHARD A

—

2,525 × —
Sell

GONZALEZ RICHARD A

—

1,670 × —
Sell

Reents Scott T

867,630.44 USD

14,140 × 61.36
Sell

Reents Scott T

2,509,001.80 USD

14,140 × 177.44
Buy

Siatis Perry C

1,094,470.20 USD

7,315 × 149.62
Buy

Siatis Perry C

372,732.47 USD

3,519 × 105.92
Buy

Siatis Perry C

421,912.25 USD

2,919 × 144.54
Sell

Siatis Perry C

2,441,295.00 USD

13,753 × 177.51
Sell

SALEKI-GERHARDT AZITA

3,112,985.80 USD

52,870 × 58.88
Sell

SALEKI-GERHARDT AZITA

9,184,048.00 USD

52,870 × 173.71
Sell

Siatis Perry C

421,912.25 USD

2,919 × 144.54
Sell

Siatis Perry C

496,230.00 USD

2,919 × 170.00
Sell

Donoghoe Nicholas

450,544.66 USD

2,912 × 154.72
Buy

Alpern Robert J

7,453.00 USD

50 × 149.06
Buy

RAPP EDWARD J

38,606.54 USD

259 × 149.06
Sell

GONZALEZ RICHARD A

—

42,000 × —
Buy

Alpern Robert J

—

129 × —
Sell

GONZALEZ RICHARD A

8,914,800.00 USD

60,000 × 148.58
Sell

GONZALEZ RICHARD A

2,759,275.00 USD

18,500 × 149.15
Buy

RAPP EDWARD J

38,667.51 USD

287 × 134.73
Sell

Strom Carrie C

421,103.90 USD

2,876 × 146.42
Buy

MEYER MELODY B

—

1,450 × —
Buy

BURNSIDE WILLIAM H.L.

—

1,450 × —
Buy

Hart Brett J

—

1,450 × —
Buy

Alpern Robert J

—

1,450 × —
Buy

Roberts Rebecca B

—

1,450 × —
Buy

FREYMAN THOMAS C

—

1,450 × —
Buy

WADDELL FREDERICK H

—

1,450 × —
Buy

TILTON GLENN F

—

1,450 × —
Buy

RAPP EDWARD J

—

1,450 × —
Buy

AUSTIN ROXANNE S

—

1,450 × —
Sell

TILTON GLENN F

336,997.60 USD

2,230 × 151.12
Sell

Sorg Elaine K.

886,030.20 USD

6,130 × 144.54
Sell

Sorg Elaine K.

1,011,450.00 USD

6,130 × 165.00
Sell

Sorg Elaine K.

81,020.00 USD

500 × 162.04
Sell

Sorg Elaine K.

1,131,318.40 USD

6,999 × 161.64
Sell

Sorg Elaine K.

1,402,687.00 USD

15,002 × 93.50
Sell

Sorg Elaine K.

2,400,770.00 USD

15,002 × 160.03
Sell

Siatis Perry C

372,838.40 USD

3,520 × 105.92
Sell

Siatis Perry C

563,200.00 USD

3,520 × 160.00
Sell

Strom Carrie C

70,070.94 USD

449 × 156.06
Sell

GONZALEZ RICHARD A

—

2,550 × —
Sell

Strom Carrie C

125,768.70 USD

810 × 155.27
Sell

Sorg Elaine K.

1,402,780.50 USD

15,003 × 93.50
Sell

Sorg Elaine K.

2,325,465.00 USD

15,003 × 155.00
Sell

Siatis Perry C

123,470.91 USD

805 × 153.38
Sell

Siatis Perry C

1,734,169.80 USD

11,330 × 153.06
Sell

Reents Scott T

130,373.01 USD

850 × 153.38
Sell

Reents Scott T

2,309,981.50 USD

15,092 × 153.06
Sell

SALEKI-GERHARDT AZITA

1,387,825.80 USD

26,990 × 51.42
Sell

SALEKI-GERHARDT AZITA

119,644.20 USD

780 × 153.39
Sell

SALEKI-GERHARDT AZITA

1,411,121.00 USD

9,220 × 153.05
Sell

SALEKI-GERHARDT AZITA

4,183,450.00 USD

26,990 × 155.00
Sell

RICHMOND TIMOTHY J.

2,572,520.50 USD

16,746 × 153.62
Sell

RICHMOND TIMOTHY J.

4,193,582.80 USD

27,395 × 153.08
Sell

Strom Carrie C

888,961.40 USD

5,762 × 154.28
Sell

Sorg Elaine K.

3,062,458.00 USD

19,850 × 154.28
Sell

Siatis Perry C

1,489,727.60 USD

9,656 × 154.28
Sell

Reents Scott T

1,956,733.20 USD

12,683 × 154.28
Sell

Durkin Brian L

1,725,159.00 USD

11,182 × 154.28
Sell

Stewart Jeffrey Ryan

3,843,114.80 USD

24,910 × 154.28
Sell

SALEKI-GERHARDT AZITA

5,146,626.50 USD

33,359 × 154.28
Sell

Hudson Thomas J

4,307,806.00 USD

27,922 × 154.28
Sell

RICHMOND TIMOTHY J.

5,416,925.00 USD

35,111 × 154.28
Sell

GONZALEZ RICHARD A

17,558,606.00 USD

113,810 × 154.28
Sell

Michael Robert A.

7,457,123.50 USD

48,335 × 154.28
Buy

Alpern Robert J

7,434.06 USD

46 × 161.61
Buy

RAPP EDWARD J

38,624.79 USD

239 × 161.61
Sell

RICHMOND TIMOTHY J.

—

42,370 × —
Sell

RICHMOND TIMOTHY J.

504,607.53 USD

3,075 × 164.10
Sell

RICHMOND TIMOTHY J.

6,420,410.00 USD

39,295 × 163.39
Buy

RICHMOND TIMOTHY J.

2,324,418.20 USD

42,370 × 54.86
Buy

RAPP EDWARD J

38,652.48 USD

288 × 134.21
Buy

Alpern Robert J

7,381.55 USD

55 × 134.21
Buy

Alpern Robert J

7,198.52 USD

47 × 153.16
Buy

RAPP EDWARD J

36,298.92 USD

237 × 153.16
Sell

SEVERINO MICHAEL

2,302,594.80 USD

21,739 × 105.92
Sell

SEVERINO MICHAEL

1,097,877.00 USD

11,742 × 93.50
Sell

SEVERINO MICHAEL

5,297,155.00 USD

46,320 × 114.36
Sell

SEVERINO MICHAEL

1,758,505.60 USD

11,605 × 151.53
Sell

SEVERINO MICHAEL

10,283,274.00 USD

68,196 × 150.79
Sell

SEVERINO MICHAEL

6,043,466.00 USD

64,636 × 93.50
Sell

SEVERINO MICHAEL

2,794,463.20 USD

35,364 × 79.02
Sell

SEVERINO MICHAEL

326,067.00 USD

2,100 × 155.27
Sell

SEVERINO MICHAEL

8,385,563.00 USD

54,279 × 154.49
Sell

SEVERINO MICHAEL

6,692,769.50 USD

43,621 × 153.43
Sell

SEVERINO MICHAEL

2,306,383.00 USD

29,121 × 79.20
Sell

SEVERINO MICHAEL

4,349,135.50 USD

70,879 × 61.36
Sell

Gosebruch Henry O

4,606,045.50 USD

83,960 × 54.86
Sell

Gosebruch Henry O

13,013,800.00 USD

83,960 × 155.00
Sell

SEVERINO MICHAEL

62,176.00 USD

400 × 155.44
Sell

SEVERINO MICHAEL

8,255,020.00 USD

53,327 × 154.80
Sell

SEVERINO MICHAEL

7,127,892.50 USD

46,273 × 154.04
Buy

SEVERINO MICHAEL

2,301,141.20 USD

29,121 × 79.02
Sell

Strom Carrie C

437,410.84 USD

2,876 × 152.09
Sell

SEVERINO MICHAEL

1,793,000.60 USD

29,221 × 61.36
Sell

SEVERINO MICHAEL

4,167,467.50 USD

70,779 × 58.88
Sell

SEVERINO MICHAEL

7,426,162.50 USD

48,591 × 152.83
Sell

SEVERINO MICHAEL

4,344,321.00 USD

28,536 × 152.24
Sell

SEVERINO MICHAEL

3,457,482.80 USD

22,873 × 151.16
Sell

SEVERINO MICHAEL

1,984,314.90 USD

33,701 × 58.88
Sell

SEVERINO MICHAEL

3,637,163.20 USD

66,299 × 54.86
Sell

SEVERINO MICHAEL

3,190,570.80 USD

21,071 × 151.42
Sell

SEVERINO MICHAEL

4,777,080.00 USD

31,714 × 150.63
Sell

SEVERINO MICHAEL

7,060,059.00 USD

47,215 × 149.53
Sell

Strom Carrie C

35,762.22 USD

234 × 152.83
Sell

SEVERINO MICHAEL

1,409,408.20 USD

25,691 × 54.86
Sell

SEVERINO MICHAEL

4,045,381.80 USD

74,309 × 54.44
Sell

SEVERINO MICHAEL

2,100,028.00 USD

13,836 × 151.78
Sell

SEVERINO MICHAEL

6,950,166.50 USD

45,988 × 151.13
Sell

SEVERINO MICHAEL

6,030,418.00 USD

40,176 × 150.10
Buy

WADDELL FREDERICK H

—

1,421 × —
Buy

TILTON GLENN F

—

1,421 × —
Buy

Roberts Rebecca B

—

1,421 × —
Buy

MEYER MELODY B

—

1,421 × —
Buy

RAPP EDWARD J

—

1,421 × —
Buy

Hart Brett J

—

1,421 × —
Buy

FREYMAN THOMAS C

—

1,421 × —
Buy

BURNSIDE WILLIAM H.L.

—

1,421 × —
Buy

AUSTIN ROXANNE S

—

1,421 × —
Buy

Alpern Robert J

—

1,421 × —
Buy

Alpern Robert J

7,132.84 USD

44 × 162.11
Buy

LIDDY EDWARD M

28,693.47 USD

177 × 162.11
Buy

RAPP EDWARD J

35,177.87 USD

217 × 162.11
Sell

Stewart Jeffrey Ryan

4,408,386.50 USD

27,690 × 159.21
Buy

Stewart Jeffrey Ryan

1,630,387.20 USD

27,690 × 58.88
Sell

Durkin Brian L

1,041,907.00 USD

6,946 × 150.00
Sell

Durkin Brian L

1,752,393.40 USD

11,682 × 150.01
Buy

Durkin Brian L

923,111.60 USD

11,682 × 79.02
Sell

Strom Carrie C

53,448.80 USD

355 × 150.56
Sell

Strom Carrie C

67,450.88 USD

448 × 150.56
Sell

Strom Carrie C

119,628.90 USD

810 × 147.69
Sell

Gosebruch Henry O

14,938.10 USD

100 × 149.38
Sell

Gosebruch Henry O

594,824.00 USD

4,000 × 148.71
Sell

Gosebruch Henry O

762,659.56 USD

5,167 × 147.60
Sell

Gosebruch Henry O

2,309,777.50 USD

15,733 × 146.81
Sell

Sorg Elaine K.

104,351.10 USD

700 × 149.07
Sell

Sorg Elaine K.

512,784.06 USD

3,451 × 148.59
Sell

Sorg Elaine K.

344,332.12 USD

2,333 × 147.59
Sell

RICHMOND TIMOTHY J.

391,654.16 USD

2,627 × 149.09
Sell

RICHMOND TIMOTHY J.

2,143,190.20 USD

14,424 × 148.59
Sell

RICHMOND TIMOTHY J.

1,383,913.20 USD

9,381 × 147.52
Sell

Stewart Jeffrey Ryan

387,493.60 USD

2,600 × 149.04
Sell

Stewart Jeffrey Ryan

1,879,772.90 USD

12,659 × 148.49
Sell

Stewart Jeffrey Ryan

918,329.00 USD

6,229 × 147.43
Sell

Gosebruch Henry O

164,207.55 USD

1,101 × 149.14
Sell

Gosebruch Henry O

1,234,008.40 USD

8,303 × 148.62
Sell

Gosebruch Henry O

825,617.06 USD

5,596 × 147.54
Sell

Michael Robert A.

631,430.90 USD

4,236 × 149.06
Sell

Michael Robert A.

3,999,875.20 USD

26,937 × 148.49
Sell

Michael Robert A.

1,758,931.90 USD

11,932 × 147.41
Sell

Durkin Brian L

1,134,859.00 USD

7,589 × 149.54
Sell

Sorg Elaine K.

1,663,632.40 USD

11,125 × 149.54
Sell

RICHMOND TIMOTHY J.

3,144,377.50 USD

21,027 × 149.54
Sell

SALEKI-GERHARDT AZITA

3,306,030.20 USD

22,108 × 149.54
Sell

SEVERINO MICHAEL

5,810,675.50 USD

38,857 × 149.54
Sell

Hudson Thomas J

2,005,032.20 USD

13,408 × 149.54
Sell

Schumacher Laura J

6,054,874.50 USD

40,490 × 149.54
Sell

Stewart Jeffrey Ryan

2,556,087.00 USD

17,093 × 149.54
Sell

Strom Carrie C

424,693.60 USD

2,840 × 149.54
Sell

Gosebruch Henry O

4,509,528.00 USD

30,156 × 149.54
Sell

Michael Robert A.

5,127,128.00 USD

34,286 × 149.54
Sell

GONZALEZ RICHARD A

15,374,506.00 USD

102,812 × 149.54
Sell

GONZALEZ RICHARD A

—

2,610 × —
Buy

GONZALEZ RICHARD A

—

157,618 × —
Buy

Schumacher Laura J

—

56,917 × —
Buy

Stewart Jeffrey Ryan

—

13,837 × —
Buy

Stewart Jeffrey Ryan

—

7,710 × —
Buy

Stewart Jeffrey Ryan

—

7,486 × —
Buy

Stewart Jeffrey Ryan

—

4,176 × —
Buy

Stewart Jeffrey Ryan

—

19,209 × —
Buy

Strom Carrie C

—

5,727 × —
Buy

Sorg Elaine K.

—

10,377 × —
Buy

Sorg Elaine K.

—

4,075 × —
Buy

Sorg Elaine K.

—

6,861 × —
Buy

Sorg Elaine K.

—

2,530 × —
Buy

Sorg Elaine K.

—

11,642 × —
Buy

SALEKI-GERHARDT AZITA

—

13,837 × —
Buy

SALEKI-GERHARDT AZITA

—

7,490 × —
Buy

SALEKI-GERHARDT AZITA

—

11,229 × —
Buy

SALEKI-GERHARDT AZITA

—

5,568 × —
Buy

SALEKI-GERHARDT AZITA

—

25,612 × —
Buy

RICHMOND TIMOTHY J.

—

13,837 × —
Buy

RICHMOND TIMOTHY J.

—

7,490 × —
Buy

RICHMOND TIMOTHY J.

—

11,978 × —
Buy

RICHMOND TIMOTHY J.

—

4,998 × —
Buy

RICHMOND TIMOTHY J.

—

22,993 × —
Buy

Gosebruch Henry O

—

8,701 × —
Buy

Gosebruch Henry O

—

14,722 × —
Buy

Gosebruch Henry O

—

7,972 × —
Buy

Gosebruch Henry O

—

36,673 × —
Buy

Michael Robert A.

—

11,565 × —
Buy

Michael Robert A.

—

16,220 × —
Buy

Michael Robert A.

—

8,857 × —
Buy

Michael Robert A.

—

40,749 × —
Buy

Durkin Brian L

—

2,754 × —
Buy

Durkin Brian L

—

3,743 × —
Buy

Durkin Brian L

—

1,897 × —
Buy

Durkin Brian L

—

8,730 × —
Buy

Hudson Thomas J

—

6,609 × —
Buy

Hudson Thomas J

—

9,483 × —
Buy

Hudson Thomas J

—

2,530 × —
Buy

Hudson Thomas J

—

11,642 × —
Buy

GONZALEZ RICHARD A

—

34,146 × —
Buy

GONZALEZ RICHARD A

—

34,937 × —
Buy

GONZALEZ RICHARD A

—

29,106 × —
Buy

GONZALEZ RICHARD A

—

133,889 × —
Buy

SEVERINO MICHAEL

—

11,565 × —
Buy

SEVERINO MICHAEL

—

17,468 × —
Buy

SEVERINO MICHAEL

—

10,477 × —
Buy

SEVERINO MICHAEL

—

48,198 × —
Buy

Schumacher Laura J

—

11,565 × —
Buy

Schumacher Laura J

—

17,468 × —
Buy

Schumacher Laura J

—

11,136 × —
Buy

Schumacher Laura J

—

51,225 × —
Sell

Strom Carrie C

338,243.30 USD

2,396 × 141.17
Buy

Strom Carrie C

197,777.69 USD

4,184 × 47.27
Buy

LIDDY EDWARD M

28,704.80 USD

212 × 135.40
Buy

RAPP EDWARD J

35,204.00 USD

260 × 135.40
Sell

Strom Carrie C

1,404,972.40 USD

10,336 × 135.93
Sell

SEVERINO MICHAEL

—

583 × —
Sell

Schumacher Laura J

—

15,905 × —
Sell

Durkin Brian L

440,564.80 USD

7,180 × 61.36
Sell

Durkin Brian L

1,515,132.90 USD

11,790 × 128.51
Sell

Schumacher Laura J

4,303,767.00 USD

78,450 × 54.86
Sell

Schumacher Laura J

6,077,593.50 USD

103,220 × 58.88
Sell

Schumacher Laura J

537,329.56 USD

4,114 × 130.61

© Eulerpool Research Systems

AbbVie Directors Dealings

In the last week, the AbbVie stock was traded 0 times by insiders. The difference is 1.00 USD.

In the last month, the AbbVie stock was traded 0 times by insiders. The difference is 1.00 USD.

In the last year, the AbbVie stock was traded 7 times by insiders. The difference is -1,107,897.49 USD.

AbbVie Stock Analysis

Abbvie Inc. is a global, research-oriented company specializing in the field of biotechnology and pharmaceuticals. It was founded in 2013 as a spin-off from Abbott Laboratories. Abbvie's headquarters are in North Chicago, Illinois, and it employs over 47,000 people in more than 75 countries worldwide. The company focuses on researching, developing, and marketing high-quality therapies for the treatment of serious and life-threatening diseases. Abbvie has several business divisions, including immunology, oncology, neurology, and virology, and is known for its investments in research and development. Its key products include adalimumab (sold under the brand name Humira) for autoimmune diseases and Imbruvica for chronic lymphocytic leukemia. Abbvie is recognized as a leading company in the biotechnology and pharmaceutical industry due to its focus on innovative therapies and medicines.

AbbVie
IssuerAbbVie
Market capitalization- USD
SymbolABBV
ISINUS00287Y1091
ISINA1J84E

7-day aggregated

—

30-day aggregated

—

365-day aggregated

-1.11 M USD

FAQ

The Basics on Insider Purchases

Profit with insiders.

Insider trades include both directors' dealings and insider sales. These insider transactions can serve as buying indicators for private investors, as they are based on insider information available to insiders. Directors' dealings are often referred to as directors' dealings. Eulerpool obtains the information directly from BaFin and the SEC.

Who is considered an insider?

An insider knows about non-publicly known circumstances surrounding publicly traded companies that can have a significant impact on the price - for example, because they have access to this insider information through their profession. Thus, insider information can be knowledge that a publicly traded company is about to undergo a capital measure or acquire a substantial stake. An insider is not necessarily a person with a professional connection to the issuer. An insider can also be close family members and persons living in the same household.

Legal Basis

Since July 1, 2002, pursuant to § 15a of the Securities Trading Act (WpHG), transactions in securities of their own company by members of the management board and supervisory board of listed companies and their family members must be promptly reported and published by the company. With the entry into force of the Investor Protection Improvement Act on October 30, 2004, the provisions of § 15a WpHG were significantly modified. With the applicability of the Market Abuse Regulation on July 3, 2016, the legal provisions on transactions by managerial personnel are regulated in Article 19 MAR. The publication of these transactions is an important contribution to the prevention of insider trading and market manipulation. In addition, knowledge of such transactions is of great importance to the market, as they provide indications of the management's assessment of future business prospects.

Reporting obligations

According to Art. 19 MAR, executives must immediately report to the issuer and the competent authority any personal transaction involving shares or debt instruments of this issuer or related derivatives or other related financial instruments, no later than three business days after the transaction date. The reporting obligation also applies to spouses, registered life partners, dependent children, and other relatives who have been residing in the same household for at least one year. The same applies to legal entities closely related to the executive, trustees (e.g., foundations) or partnerships acting as trustees. Personal transactions are subject to reporting as soon as the total amount reaches EUR 5,000 by the end of the calendar year. With effect from 01.01.2020, BaFin has increased the threshold from EUR 5,000 to EUR 20,000 through a general ruling.

Publication obligations

The issuer is responsible for publishing reportable transactions within two business days after receiving a corresponding notification from the executive or a closely related person through appropriate media throughout the European Union. Additionally, the issuer is obligated to transmit the published information to the company registry, which stores it.

What are Directors Dealings?

Directors Dealings and insider sales can be summarized under the term insider trading. In English, the term Directors Dealings is commonly used.

These are purchases and sales of stocks by individuals who have insider information about the respective company.

But who is even considered an insider?

An insider is aware of non-publicly known circumstances surrounding publicly traded companies, which can have a significant impact on the price - for example, because they have obtained this insider information due to their profession.

An insider information can be the knowledge that a listed company is about to undertake a capital measure or acquire a significant stake.

An insider is not necessarily a person with a professional connection to the issuer. It can also refer to close family members and individuals residing in the same household.

Insider trading is prohibited.

It is important to understand that insider trading is prohibited.

A publicly traded company must disclose all information that could potentially affect the stock price as soon as possible. It is illegal for an insider to buy or sell shares based on this information that has not yet been disclosed.

So it should be clear that the published insider trades usually do not refer to trades that have a significant short-term impact on the stock price of a publicly traded company.

Rather, insider trades are about an insider's belief in a positive or negative future development of the company.

However, the normalization of (legal) insider trades does not mean that they cannot have an impact on the stock price.

Insider obligations

If you are a member of the executive board, the supervisory board, or a top-level executive of a publicly traded company and you buy or sell shares of your own company based on insider information, you must notify the company immediately (within 3 business days).

The company must then promptly (within 2 business days) disclose this information.

The same applies to family members of the mentioned individuals and other involved parties, such as legal entities closely associated with the insider, fiduciary institutions (e.g. foundations), or partnerships.

The reporting threshold has been set at 20,000 euros per calendar year since 2020 (previously 5,000 euros).

The mentioned information pertains to German companies.

How does the Eulerpool Directors Dealings Tool work?

With the Eulerpool Directors Dealings Tool, you can easily find out which Directors Dealings are available at German companies in the last 7, 30, or 365 days occurred. Directors Dealings of shares from the USA will be added in the near future.

In principle, you have two options to use the Directors Dealings Tool:
  • Search for directors dealings of a specific stock within the timeframe of 7, 30, or 365 days.
  • Search for all directors dealings in the period of 7, 30, or 365 days.

Option 1: Search for directors dealings of a specific stock.

If you want to check whether there has been any insider trading activity for a particular stock recently, you can search for it using the stock's name or the stock's ISIN.

Option 2: Search for all directors dealings

If you want to know which Directors Dealings have occurred in all German stock companies recently, Eulerpool's Directors Dealings Tool can also help you.

Simply call up the page and select the desired time period, and you will immediately see all Directors Dealings in the table. But how do you read the table?

So how to read the table

The table consists of the following 6 columns:
  • Issuer
  • ISIN
  • Purchase volume
  • Sales volume
  • Number
  • Difference

Issuer/ISIN

With the names (issuer) and ISIN, you can uniquely identify a stock. By clicking on both parameters, you will get more information about insider trading for the selected stock. But more on that later.

Purchase and Sales Volume

When looking at the buying and selling volume, you can see how much volume of stocks has been traded in insider trades. For example, if a stock is worth 100 euros and an insider buys it 100 times, you will see a value of 10,000 euros in the buying volume column. If an insider has sold stocks for the same amount, you will see the 10,000 euros in the selling volume.

Difference

The difference is calculated by the buying and selling volume. If an insider trading transaction involves buying a volume of 100,000 euros, but only selling 50,000 euros, you will see a green value of 50,000 euros in the difference. In the case of a negative difference, you will see a red number with a minus sign in front. This indicates that more shares were sold than bought in insider trades.

Number

The number indicates how much insider trading has occurred at the respective company. Both purchases and sales are included here.

Sort table

Now you know how to read the table. However, if you use option 2, you still need to sort the results. At Eulerpool's Directors Dealings Tool, you can sort all columns from top to bottom (or vice versa).

If you click on, for example, "purchase volume", the results will be sorted in descending order based on purchase volume as the leading criterion. If you click on it again, the sorting will change from descending to ascending.

The same is also possible with all other columns. Every time you click on the respective column, it will become the leading criterion for sorting the results.

You can customize the results for insider trading according to your preferences. If you have found a stock that is noticeable to you, for example, due to a high number of directors dealings or a significant difference, you naturally want to gather more information. As mentioned briefly before, the Directors Dealings Tool from Eulerpool also assists you with that.

Further information about insider trading

By clicking on issuer or ISIN, you will be directed to a page with further information about the company. In addition to the business model and stock price of the company, you can see how much insider trading has occurred in the last 7, 30, and 365 days (number, difference).

As a special highlight, you can see in the table notifications who exactly made the insider trade. In addition to the obligated party, you can see the volume of the trade, the insider's position (including close relationship, executive board), the stock price at the time of the trade, the number of shares traded, and the date of the trade. This way, you can track all directors dealings in detail.

Now you can start further research and find out with qualitative information what exactly led to the insider trade.

Where does the data on insider trading come from?

Finally, the answer to an important question. We obtain the data from the Eulerpool Directors Dealings Tool directly from the Federal Financial Supervisory Authority (BaFin).

For the Directors Dealings of stocks from the USA, we will rely on data from the United States Securities and Exchange Commission (SEC) in the future.

We are also providing the Equity Screening with the highest possible data quality.

Why insider trading is prohibited and how you as an investor can still benefit from it.

In the section "What are Directors Dealings?" we have informed, among other things, about the duties of insiders. But why does insider trading actually have to be reported?

Insider trading can influence the price.

To repeat: In the case of publicly traded companies, any information that could affect the stock price must be disclosed. This is clear to everyone when it comes to Quarterly results and the like. However, directors' dealings can also influence a stock price.

Let's imagine that the CEO of a company, which has reported excellent numbers recently, suddenly sells a larger portion of his own stocks. If you are invested in this company, the CEO's stock sale would definitely be relevant information for you. Perhaps the sale is an indicator of weaker future performance or other deficiencies within the company. After all, if the CEO doesn't have the best information about the company, then who does?

If the CEO were not required to disclose his sale, you will understand why (undisclosed) insider trading is prohibited. The CEO has eliminated an unfair advantage by having access to privileged information compared to the investors.

Of course, it is also prohibited and even illegal if, for example, the CEO buys or sells stocks based on ad-hoc mandatory information. If he knows, for example, about an impending bankruptcy that is not yet publicly known, he is not allowed to sell any stocks.

Basically, in Germany, insider trading is also prohibited during the publication of Quarterly results and during the period of the initial public offering (IPO).

In summary, it can be said that without these mechanisms, the functioning of the capital market would be at risk.

You can benefit from insider trading.

Since insider trading must be disclosed, as a private investor you can benefit from it.

However, it is important to note that a decision for or against a stock should never be based solely on insider trading. Ultimately, only the pure fact of the purchase or sale is initially at stake. The reasons behind it will only be known later, or in many cases, not at all.

It should also be considered that executives are often biased towards their own company. Accordingly, they may perceive the future of the company more positively than it actually is and buy stocks of the company based on this perception. In such cases, there are no insider information available. It is also possible that executives may intentionally purchase stocks in order to positively influence the company's stock price.

Who is the insider?

Another important question when evaluating an insider trade is: Who is the insider in the first place? In general, the following can be stated: The higher-ranking the insider, the more relevant the insider trading. The reason for this is logical, as a higher-ranking person will generally have the best information.

Assessing directors dealings and sales differently

To conclude this chapter, we want to highlight an important point from our perspective. Namely, that purchases and sales should not be considered equivalent.

Directors' dealings are a (slightly) positive indicator.

We can ask ourselves the simple question of why we buy a stock. The answer is in 99.9% of cases, because we want to achieve a positive return. And likely, executives also buy stocks for the same reason in the majority of cases.

As mentioned in the previous section, there may not necessarily be groundbreaking insider information here.

However, an insider purchase can still be a (strongly) positive indicator. But only if the insider buys the stocks with their own money. On the other hand, stocks or options packages as part of compensation are not a positive indicator, as no conscious decision is made for the company in this case.

Even more positive is to see a company where there have been several purchases by one person or purchases by multiple persons recently. In such a company, a more in-depth analysis is recommended. You can find these companies using Eulerpool's Directors Dealings Tool.

Insider sales are a (strong) negative indicator.

There can be many reasons why an investor sells stocks. However, investors should be cautious when larger sell-offs by board members or institutional investors occur. This type of selling signal can indicate problems or uncertainties within the company and may cause the stock price to fall. It is advisable to closely monitor such sales and analyze the background before making a selling decision yourself. When it comes to sales, it is important to keep a cool head and not act purely out of panic. Instead of selling blindly, you should engage with the facts, make an informed decision, and possibly seek the opinion of a financial advisor.

But when it comes to insider sales, it is probably worth taking a closer look than with directors dealings. Especially when the company is actually doing well externally.

It is also important to know how many own shares the insider sold. At 5%, it is naturally less relevant than at 50%.

If a CEO, for example, sells, then one should definitely take a closer look.

Always assess the context.

But here too, the same applies. Without a context, It is difficult to assess the whole. This becomes clear with an example from the recent past.

Elon Musk has sold billions of dollars' worth of shares as CEO of Tesla. Without context, this headline would likely imply a (strongly) negative impact on Tesla's stock. However, since the sale was made to finance the acquisition of Twitter, the sale can be seen in a different (more positive) light.

We do not want to make a statement about the sense or nonsense of these measures, but rather illustrate how strongly the context categorizes insider trading.

What does science say about insider trading?

To conclude the article, we would like to briefly discuss what science says about insider trading. Because insider trades have already been examined in a variety of scientific studies.

In general, it can be stated that insider trades can provide information about future returns. In this regard, directors' dealings on average have a greater positive impact on the stock price than insider sales have a negative impact on it.

The science also confirms that insider trades by higher-ranking individuals have a greater impact on the stock price.

Also just logical. The larger the trade, the more relevant. The more people make the trade, the more relevant.

Finally, however, there is one new piece of information from science for this article. It has been found that insider trades have a greater impact on the price of smaller companies than on larger ones.

Further scientific information can be found, for example, at 2iQ Research and The Evidence-Based Investor.